888-794-0077 info@advancedtherapies.com
  • Twitter
  • Twitter
WuXi Advanced Therapies
  • Discovery
  • Manufacturing
    • Phase
      • Clinical Manufacturing
      • Commercial Manufacturing
    • Platforms
      • AAV Vector Suspension
      • Lentiviral Vector
      • Closed Process CAR-T
    • Products
      • Cell Banks
      • Cellular Therapies
      • Viral Products
      • Plasmid Manufacturing
  • Testing
    • Services
      • Analytical Development
      • Cell Line Characterization
      • Lot Release
      • Materials Characterization
      • Viral Clearance Validation
  • Resources
    • Customer Toolbox
    • Knowlege Library
  • About Us
    • Our Story
    • Careers
    • News
    • Locations
    • Events
  • Contact
    • Sales
    • Support
Select Page

By using this site, you agree to our updated Privacy and Cookie Policy.

WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers

Oct 17, 2021

Philadelphia, 17 October 2021 – WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading...

Categories

  • Events
  • News
  • Uncategorized
  • Terms of Use
  • Privacy Policy
  • Quality
Accelerating Progress and Time to Market
  • Twitter
© Copyright 2020 WuXi AppTec. All Rights Reserved.